Research Article

The Status of Antioxidants and Oxidative Damage in Patients with COVID-19

Volume: 7 Number: 1 April 16, 2023
EN TR

The Status of Antioxidants and Oxidative Damage in Patients with COVID-19

Abstract

Purpose: COVID-19 is a viral disease that has recently caused a pandemic and significantly affects human health. In this study, superoxide dismutase, glutathione peroxidase, glutathione, total thiol, natural thiol, disulfide, oxidative DNA damage and malondialdehyde levels in COVID-19 were investigated. Materials and Methods: Thirty-five patients and 35 healthy volunteers were included in this study. The diagnosis of COVID-19 was made by reverse transcriptase-polymerase chain reaction. Serum glutathione, glutathione peroxidase, superoxide dismutase, natural thiol, total thiol and disulphide levels by enzyme-linked immunosorbent assay and malondialdehyde and 8-hydroxy-2-deoxyguanosine/10⁶ deoxyguanosine levels by high-pressure liquid chromatography measured. Results: While serum superoxide dismutase, glutathione peroxidase, malondialdehyde, 8-hydroxy-2-deoxyguanosine/10⁶ deoxyguanosine, disulfide levels were higher in the COVID-19 patient group than in the healthy control group, glutathione, total thiol, natural thiol levels were lower. In addition, there was a negative correlation between 8-hydroxy-2-deoxyguanosine/10⁶ deoxyguanosine and glutathione, natural thiol and total thiol, and a positive correlation with disulfide. Conclusion: This study revealed that serum superoxide dismutase, glutathione peroxidase, malondialdehyde, 8-hydroxy-2-deoxyguanosine/10⁶ deoxyguanosine, and disulfide levels increased and glutathione, thiol and natural thiol levels decreased in COVID-19 patients. These results revealed that there was a decrease in antioxidant marker levels and an increase in oxidative stress markers in COVID-19 patients.

Keywords

Supporting Institution

Yok

Project Number

YOK

Thanks

Van Yüzüncü Yıl Üniversitesi Tıp Fakültesi Biyokimya Anabilim Dalı'na katkılarından dolayı teşekkür ederiz.

References

  1. 1. Fakhri S, Nouri Z, Moradi SZ, Farzaei MH. Astaxanthin, COVID-19 and immune response: Focus on oxidative stress, apoptosis and autophagy. Phytother Res. 2020;34(11):2790-2792.
  2. 2. Saleh J, Peyssonnaux C, Singh KK, Edeas M. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion. 2020;54:1-7.
  3. 3. Zhang R, Wang X, Ni L et al. COVID-19: Melatonin as a potential adjuvant treatment. Life Sci. 2020;250:117583.
  4. 4. Cecchini R, Cecchini AL. SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression. Med. Hypotheses. 2020;143:110102.
  5. 5. Derouiche S. Oxidative Stress Associated with SARS-Cov-2 (COVID-19) Increases the Severity of the Lung Disease - A Systematic Review. J Infect Dis Epidemiol. 2020;6(3):1-6.
  6. 6. Panfoli I. Potential role of endothelial cell surface ectopic redox complexes in COVID-19 disease pathogenesis. Clin Med. 2020;20(5):146-147.
  7. 7. Garcia JB, Verdegal RO, Pallardo FV et al. Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression. Antioxidants. 2020;9(10):936.
  8. 8. Kalyanaraman B. Do free radical NETwork and oxidative stress disparities in African Americans enhance their vulnerability to SARS-CoV-2 infection and COVID-19 severity? Redox Biol. 2020;37: 101721.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Publication Date

April 16, 2023

Submission Date

August 2, 2022

Acceptance Date

March 9, 2023

Published in Issue

Year 2023 Volume: 7 Number: 1

APA
Binici, İ., Alp, H. H., Huyut, Z., Gürbüz, E., Günbatar, H., Akmeşe, Ş., Karahocagil, M. K., & Akbay, H. İ. (2023). The Status of Antioxidants and Oxidative Damage in Patients with COVID-19. Ahi Evran Medical Journal, 7(1), 114-123. https://doi.org/10.46332/aemj.1152479
AMA
1.Binici İ, Alp HH, Huyut Z, et al. The Status of Antioxidants and Oxidative Damage in Patients with COVID-19. Ahi Evran Med J. 2023;7(1):114-123. doi:10.46332/aemj.1152479
Chicago
Binici, İrfan, Hamit Hakan Alp, Zübeyir Huyut, et al. 2023. “The Status of Antioxidants and Oxidative Damage in Patients With COVID-19”. Ahi Evran Medical Journal 7 (1): 114-23. https://doi.org/10.46332/aemj.1152479.
EndNote
Binici İ, Alp HH, Huyut Z, Gürbüz E, Günbatar H, Akmeşe Ş, Karahocagil MK, Akbay Hİ (April 1, 2023) The Status of Antioxidants and Oxidative Damage in Patients with COVID-19. Ahi Evran Medical Journal 7 1 114–123.
IEEE
[1]İ. Binici et al., “The Status of Antioxidants and Oxidative Damage in Patients with COVID-19”, Ahi Evran Med J, vol. 7, no. 1, pp. 114–123, Apr. 2023, doi: 10.46332/aemj.1152479.
ISNAD
Binici, İrfan - Alp, Hamit Hakan - Huyut, Zübeyir - Gürbüz, Esra - Günbatar, Hülya - Akmeşe, Şükrü - Karahocagil, Mustafa Kasım - Akbay, Halil İbrahim. “The Status of Antioxidants and Oxidative Damage in Patients With COVID-19”. Ahi Evran Medical Journal 7/1 (April 1, 2023): 114-123. https://doi.org/10.46332/aemj.1152479.
JAMA
1.Binici İ, Alp HH, Huyut Z, Gürbüz E, Günbatar H, Akmeşe Ş, Karahocagil MK, Akbay Hİ. The Status of Antioxidants and Oxidative Damage in Patients with COVID-19. Ahi Evran Med J. 2023;7:114–123.
MLA
Binici, İrfan, et al. “The Status of Antioxidants and Oxidative Damage in Patients With COVID-19”. Ahi Evran Medical Journal, vol. 7, no. 1, Apr. 2023, pp. 114-23, doi:10.46332/aemj.1152479.
Vancouver
1.İrfan Binici, Hamit Hakan Alp, Zübeyir Huyut, Esra Gürbüz, Hülya Günbatar, Şükrü Akmeşe, Mustafa Kasım Karahocagil, Halil İbrahim Akbay. The Status of Antioxidants and Oxidative Damage in Patients with COVID-19. Ahi Evran Med J. 2023 Apr. 1;7(1):114-23. doi:10.46332/aemj.1152479

Cited By

Ahi Evran Medical Journal  is indexed in ULAKBIM TR Index, Turkish Medline, DOAJ, Index Copernicus, EBSCO and Turkey Citation Index. Ahi Evran Medical Journal is periodical scientific publication. Can not be cited without reference. Responsibility of the articles belong to the authors.

    Creative Commons Lisansı

This journal is licensed under the Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı.